AI in medicine: A win-win for doctors and patients
Digitalization is making healthcare both more efficient and better. Central Hessen’s researchers and industry are pushing the future of digital healthcare.
Research & Development
The future of medicine is based on intensive research. Innovations from genetic research and digitization, for example, are revolutionizing medicine and healthcare more than ever before. Strong entrepreneurs are also needed to turn scientists’ results into real products and help to improve patients’ diagnosis, prevention, therapy, nursing and rehabilitation. These stories provide insights into the top research and development in central Hessen and show the latest trends – always for the benefit of patients all over the world.
Rare diseases: more frequent than you think
In Central Hesse, a strong network of industry and research creates special attention and help for patients with rare diseases. Sabine Pitschula is one of … Weiterlesen
“With our antimicrobial coating, surfaces can be permanently germ-free”
After 15 minutes, surfaces can become 99 percent germ-free after: Chemist Dr. Klaus Schepers explains how this occurs. Schepers is the founder of Munditech, which produces plant-based, antimicrobial coatings.
Middle Hessen and the Corona crisis: healthcare innovations against viruses
Scientists are racing to get the Corona pandemic under control. Research institutes and companies from Central Hessen are making major contributions and developing new long-term research strategies.
Donating plasma during COVID-19
Why is donating blood plasma so important? Plasma serves as a raw material for the production of life-saving drugs. To ensure the production of these therapeutics, plasma donors are urgently needed – especially, now, during the pandemic.
“A single lab value buried inside 6 kilograms of data”: Solving rare medical mysteries
At the Center for Unknown and Rare Diseases (ZusE) at Marburg University Hospital, patients find help from Prof. Juergen Schaefer.
Helping less privileged people around the globe
DFG President Prof. Dr. Katja Becker has dedicated her life as a researcher to one goal in particular: to develop new drugs and diagnostics against poverty-associated and neglected infectious diseases.
COVID 19 study: The inhalation of messenger substances to avoid severe lung damage
In the search for medicines to treat COVID-19, lung researchers from Giessen are testing an existing active ingredient that has already been proven to prevent lung damage.